Title: Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial
Authors: Brunner, Hermine I ×
Ruperto, Nicolino
Zuber, Zbigniew
Keane, Caroline
Harari, Olivier
Kenwright, Andrew
Lu, Peng
Cuttica, Ruben
Keltsev, Vladimir
Xavier, Ricardo M
Calvo, Inmaculada
Nikishina, Irina
Rubio-Pérez, Nadina
Alexeeva, Ekaterina
Chasnyk, Vyacheslav
Horneff, Gerd
Opoka-Winiarska, Violetta
Quartier, Pierre
Silva, Clovis A
Silverman, Earl
Spindler, Alberto
Baildam, Eileen
Gámir, M Luz
Martin, Alan
Rietschel, Christoph
Siri, Daniel
Smolewska, Elzbieta
Lovell, Daniel
Martini, Alberto
De Benedetti, Fabrizio
for the Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG)
Contributors: Wouters, Carine
Issue Date: Jun-2015
Publisher: H.K. Lewis
Series Title: Annals of the Rheumatic Diseases vol:74 issue:6 pages:1110-1117
Article number: annrheumdis-2014-205351
Abstract: To evaluate the interleukin-6 receptor inhibitor tocilizumab for the treatment of patients with polyarticular-course juvenile idiopathic arthritis (pcJIA).
ISSN: 0003-4967
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Laboratory of Pediatric Immunology
× corresponding author

Files in This Item:
File Description Status SizeFormat
Efficacy and safety of tocilizumab.pdf Published 1342KbAdobe PDFView/Open Request a copy

These files are only available to some KU Leuven Association staff members


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science